UniQuest is Australia's leading commercialising entity.

We specialise in commercialising the intellectual property of The University of Queensland and benchmark in the top tier of technology transfer worldwide. 

Our Vision

To facilitate commercialisation to achieve profound commercial, environmental and social benefits as impact for UQ.

Our Mission

To commercialise UQ's intellectual property, expertise and research outcomes to create demonstrable value for UQ, for society, and to do so in a way that is financially self-sustaining.


UniQuest builds industry engagement and commercialisation outcomes for UQ. 

Our Channels to Market

Our Values

Act with Integrity

We act with honesty, integrity and professionalism and uphold the highest ethical standards. We are committed to transparency and accountability to our shareholders and customers.

We work in the best interests of UniQuest and the UniQuest team. Our personal interests are secondary to UniQuest's best interests.



We build long-term trusted relationships with our internal and external customers for mutual benefit.



We trust in the integrity, strength and ability of UniQuest and its staff to fulfil its promises and commitments. We respect our colleagues and partners and work together for shared success.



We are receptive to new ideas. We are accessible to our colleagues and partners to enable effective and positive working relationships and to respond to both personal needs and business opportunities.




We are

Our clients are the centre of our world. We listen, understand and tailor solutions.


We understand one size won't fit all when it comes to structuring research collaborations and commercial deals. We are flexible about deal structures to ensure we forge valuable and enduring partnerships and win/win outcomes. 
We come from industry and are highly networked. We are aware of the issues affecting industry and are motivated to partner and solve real-world problems.
Business savvy
We are professionals who understand industry needs.  Our place in the supply chain is between academia and industry.
Structured for results
Our business is structured into four easy-to-access market channels through which we locate the world-class expertise and innovation you seek. 
Local and global
We collaborate with clients who are small, medium and large, span every market sector and are in every corner of the globe.
Browse our more than 30+ commercialisation stories to discover the depth and breadth of our success.  


Our History

UQ’s seventh Vice-Chancellor Professor Brian Wilson, arrived at UQ and saw the tremendous potential of UQ’s cutting edge research in areas ranging from energy to mining and agriculture.  He saw the potential to commercialise research outcomes to solve industry problems and build UQ’s financial independence.
The vision of Vice-Chancellor Professor Brian Wilson led to the establishment of UniQuest in July 1984 as UQ’s research and expertise commercialisation company, wholly owned by UQ.  UniQuest started with one desk, two chairs, a telephone and seed funding of $155,000 from the university.
In its second year of business, UniQuest made a net profit of $200,000 by commercialising a technology for the efficient conversion of sugar-cane syrup to ethanol and fructose and the economic conversion of waste products to protein.
UniQuest managed its first commercial consultancy project.
UniQuest filed the patent application for the cervical cancer vaccine co-invented by Professor Ian Frazer and the late Dr Jian Zhou.
UniQuest’s Consulting & Research Division was formed.
UniQuest commercialised the cervical cancer vaccine technology with CSL who subsequently sublicensed it to Merck & Co., Inc. UniQuest’s International Development Division was formed.
UniQuest commercialised the magnetic resonance imaging technology of Professor Stuart Crozier.
The Positive Parenting Program developed by Professor Matt Sanders was licensed to Triple P International to commercialise globally.
UniQuest ran its first Research Commercialisation Workshop, to increase commercialisation awareness among UQ researchers.  This is now an annual event.
The Pathfinder Proof of Concept funding program commenced.
The first commercial sale of the Gardasil cervical cancer vaccine by Merck & Co., Inc.
UniQuest’s annual revenue now $100 million. UniQuest expanded to provide commercialisation services for 6 other Australian universities and research institutes.
UniQuest refocussed its core strategy and business objectives to maximise the impact of UQ’s research outcomes through commercialisation; and restructured its business and realigned its approach to service UQ only.


UniQuest’s newly positioned and rebranded business is designed to build industry engagement and commercialisation outcomes for UQ.


Available Innovations
Novel adjuvant to re-sensitise antibiotic-resistant bacteria to treat pyoderma

Researchers from The University of Queensland have identified adjuvants which can re-sensitise tetracycline-resistant strains of group A streptococcus and restore its activity in a skin infection model.

Active Filter Plasma

A Novel NOx and Particulate Matter Filter Using Non-Thermal Plasma (NTP)

Rapid Nucleic Acid Extraction

The ability to amplify and detect specific DNA sequences

Molecular Clamp: a novel protein vaccine for influenza, RSV, Ebola and other viruses

A Qualitative Method to Improve Alarm Management for Plant Safety and Efficiency

A novel, qualitative approach to analysis of alarms at each stage of the alarm system lifecycle.